Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:e53-e65
Published online before print January 29, 2009, doi: 10.1161/STROKEAHA.108.536953
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3/e53    most recent
STROKEAHA.108.536953v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barnett, H. J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnett, H. J.M.
Related Collections
Right arrow AHA Statements and Guidelines
Right arrow Other Stroke Treatment - Medical

(Stroke. 2009;40:e53.)
© 2009 American Heart Association, Inc.


Special Report

Personal Reflections From a Front-Row Seat at the Greatest Show on Earth (Life)

Part II (Stroke Research Commentary)

Henry J.M. Barnett, CC, MD, FRCP(c), FRCP(UK), FACP

From the University of Western Ontario (Professor Emeritus), and the Robarts Research Institute (Scientist Emeritus), Ontario, Canada.

Correspondence to Henry JM Barnett, Professor Emeritus University of Western Ontario, Scientist Emeritus Robarts Research Institute, 14865 Concession 7, King City, Ontario, Canada L7B1K4. E-mail hjmb@sympatico.ca.


Key Words: acute stroke


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Part I of this discussion of my 65 years since graduating from medical school covered my reasons for being in medicine at all, my explanation for the theatrical terms in the earlier para-scientific document, and finally the effect of World War II on my career.1

Part II will attempt to touch on the privileged life I led in the field of stroke prevention research. In its entirety it is designed as a story or tale about my 50 years in medical practice and does not follow the standard format of a scientific paper.

Previously I alluded to the ongoing prejudicial custom of critical attempts to resist new ideas in scientific endeavor. I gave as examples the discordant behavior in Toronto that greeted the discovery of insulin and of less far-reaching consequence my own attempts to convince Canadian and American colleagues that there were 5 distinct causal mechanisms leading to syringomyelia. Surgeons in Cleveland and Boston were adamant that there was but one. Postmortem studies and now routine MR studies prove them wrong.


*    New Insights Into Previously Unrecognized Causes of Stroke
 
My next contribution of a controversial nature was a description of a group of young patients with stroke whose causes we defined in a study with age and gender-matched controls as being due to emboli associated with mitral valve prolapse and to suggest that this was a clinically overlooked cause of cerebral ischemic events.2 Denials of variable vehemence appeared but the accumulating pathological and surgical data were quite incontrovertible. Ultimately in an Olmstead County prevalence study its occurrence . . . [Full Text of this Article]